Anales de la RANM

200 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 CÁNCER DE PENE EN UN HOSPITAL DE TERCER NIVEL DE LA CIUDAD DE MÉXICO Angulo Lozano JC, et al. An RANM. 2022;139(02): 196 - 201 1. Djajadiningrat RS, Van Werkhoven E, Mein- hardt W et al. Penile sparing surgery for peni- le cancer: does it affect survival? J Urol. 2014; 192(1): 120-125. https://doi.org/10.1016/j. juro.2013.12.038 2. Vieira CB, Feitoza L, Pinho J et al. Profile of patients with penile cancer in the region with the highest worldwide incidence. Sci Rep. 2020; 10: 1-7. 3. Jiménez Ríos MA, Solares Sánchez M, Mar- tínez Cervera P et al. Penile cancer. INCAN Mexico. 2011. http://incan-mexico.org/re- vistainvestiga/elementos/documentosPorta- da/1298053577.pdf 4. Reynoso N, Scavuzzo A, Santana Rios Z et al. Cáncer de pene en México: 20 años de expe- riencia en un hospital académico de tercer ni- vel (Penile cancer in Mexico: Twenty years ex- perience at a tertiary academic hospital). Arch Esp Urol. 2020; 73(1):11-18. Spanish. PMID: 31950918. 5. Chaux A, Velázquez EF, Amin A et al. Distribu- tion and characterization of subtypes of penile intraepithelial neoplasia and their association with invasive carcinomas: a pathological stu- dy of 139 lesions in 121 patients. Hum Pathol. 2012; 43: 1020-1027. 6. PDQ Adult Treatment Editorial Board. PDQ Cancer Information Summaries (Internet). National Cancer Institute (US); Bethesda (MD): 2021. Penile Cancer Treatment (PDQ®): Health Professional Version. 7. Slongo J, Giuliano AR, Johnstone PA, Spiess PE. The relationship between HPV and penile cancer: Filling a knowledge gap in the general population. Can Urol Assoc J. 2019; 13(2): 38. 8. Cubilla AL, Lloveras B, Alejo M et al. The ba- saloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Pa- raguay. Am J Surg Pathol. 2010; 34: 104-114. 9. Daling JR, Madeleine MM, Johnson LG et al. Penile cancer: Importance of circumci- sion, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005; 116(4): 606-616. doi: 10.1002/ijc.21009. PMID: 15825185. 10. Tsen, HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: Results of a po- pulation-based case-control study in Los An- geles County (United States). Tsen HF, Mor- genstern H, Mack T, Peters RK. Risk factors for penile cancer: Results of a population-ba- sed case-control study in Los Angeles County (United States). Cancer Causes Control. 2001 Apr;12(3):267-77. 2001; 12(3): 267-277. http:// www.jstor.org/stable/3553680. 11. Cubilla AL, Lloveras B, Alejo M et. al.: The ba- saloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Para- guay. Am J Surg Pathol. 2010; 34(1): 104-114. 12. Jayaraj R, Kumarasamy C, Sabarimurugan S, Madhav MR. Meta-analysis of penile can- cer: Conceptual interpretations. Lancet On- col. 2019; 20(3): e125-e125. https://doi. org/10.1016/S1470-2045(19)30023-3 13. Slongo J, Giuliano AR, Johnstone PA, Spiess PE. The relationship between HPV and pe- nile cancer: Filling a knowledge gap in the general population. Can Urol Assoc J. 2019; 13(2): 38. 14. Partin AW, Dmochowski RR, Kavoussi LR, Peters CA, Wein AJ, editors. Campbell Walsh Wein Urology. Philadelphia: Elsevier, 2020. 15. Cubilla AL, Dillner J, Amin MB et. al. Tu- mours of the penis: Malignant epithelial tu- mours. En: Moch H et al. World Health Orga- nization classification of tumours: Pathology and genetics of tumours of the urinary sys- tem and male genital organs. Lyon: IARC, 2016. p. 262-276. 16. Engelsgjerd JS, LaGrange CA. Penile can- cer. (Updated 2021). En: StatPearls [Internet]. Treasure Island (FL): StatPearls; 2022. https:// www.ncbi.nlm.nih.gov/books/NBK499930/ 17. Hegarty PK, Eardley I, Heidenreich A et al. Penile cancer: Organ‐sparing techniques. BJU Int. 2014; 114(6): 799-805. https://doi. org/10.1111/bju.12338 18. Monstrey S, D’Arpa S, Claes K et al. Plastic surgery: Volume 4: Lower extremity, trunk, and burns, 2018; 13: 292-322.e3 19. Hakenberg OW, Compérat EM, Minhas S, Nec- chi A, Protzel C, Watkin N. European Associa- tion of Urology: Penile cancer. Eur Urol. 2015; 67: 142-150. https://uroweb.org/guideline/ penile-cancer/ 20. Zhu Y, Gu WJ, Xiao WJ et al. Important the- rapeutic considerations in t1b penile Can- cer: Prognostic significance and adherence to treatment guidelines. Ann Surg Oncol. 2019; 26(2): 685-691. 21. Minhas S, Manseck A, Watya S, Hegarty PK. Penile cancer: Prevention and premalignant conditions. Urology. 2010; 76(2): S24-S35. https://doi.org/10.1016/j.urology.2010.04.007 22. Hakenberg OW, Dräger DL, Erbersdobler A, Naumann CM, Jünemann KP, Protzel C. The diagnosis and treatment of penile cancer. Dtsch Arztebl Int. 2018; 115(39): 646-652. doi:10.3238/arztebl.2018.0646 23. Thomas A, Necchi A, Muneer A et al. Peni- le cancer. Nat Rev Dis Primers. 2021; 7(1): 11. doi:10.1038/s41572-021-00246-5 24. Daling JR, Madeleine MM, Johnson LG et al. Penile cancer: Importance of circumcision, human papillomavirus and smoking in in situ and invasive disease . Int. J. Cancer 2005; 116(4): 606-616. doi:10.1002/ijc.21009 25. Albero G, Villa LL, Lazcano-Ponce E et al. Male circumcision and prevalence of geni- tal human papillomavirus infection in men: a multinational study. BMC Infect Dis. 2013; 13(1). doi:10.1186/1471-2334-13-18 26. De Martel C, Plummer M, Vignat J et al. World- wide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141: 664-670. 27. NCCN Guidelines Version 2.2020 Penile Can- cer. BIBLIOGRAPHY